Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132538) titled 'Study on the Mechanism of Paeoniflorin Alleviating Oxidative Stress in Cerebral Ischemia-Reperfusion Injury via the Smurf1/Keap1 Pathway' on Sept. 15.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Suzhou Hospital of Integrated Traditional Chinese and Western Medicine
Condition:
Cerebral ischemia-reperfusion injury
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-01-08
Target Sample Size: Cases of successful recanalization and thrombolysis:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=33...